Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components

Overview of attention for article published in Frontiers in Molecular Biosciences, October 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,518 followers.

New Research: Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components https://t.co/4vxzCD5lQq #MolBioSci

08 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.